Search research articles
Contact Us
Filters
Showing results (101-110 of 133) with videos related to
Page
of 14
Sort By:
Endocrine
|
December 23, 2024
Organ-specific response to [<sup>177</sup>Lu]DOTATATE peptide receptor radionuclide therapy (PRRT) assessed by sequential [<sup>68</sup>Ga]DOTATOC PET/CT in patients with metastatic small intestine neuroendocrine tumors
Darejan Mamulashvili Bessac, Philippe Baltzinger, Nathan Poterszman, et al.
Journal of Clinical Medicine
|
September 29, 2017
History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs
Emmanuel Andrès, Rachel Mourot-Cottet, Frédéric Maloisel, et al.
QJM : Monthly Journal of the Association of Physicians
|
January 11, 2017
Idiosyncratic drug-induced neutropenia & agranulocytosis
Emmanuel Andrès, Rachel Mourot-Cottet, Frédéric Maloisel, et al.
Drugs - Real World Outcomes
|
October 18, 2016
Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases
Rachel Mourot-Cottet, Frédéric Maloisel, François Séverac, et al.
Endocrine
|
July 1, 2017
Management of gastric neuro-endocrine tumours in a large French national cohort (GTE)
Sylvain Manfredi, Thomas Walter, Eric Baudin, et al.
Annals of Surgery
|
March 21, 2018
Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study from the French Group of Endocrine Tumors (GTE)
Bérénice Rault-Petit, Christine Do Cao, Serge Guyétant, et al.
Advances in Therapy
|
April 14, 2022
Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study
Denis Smith, Côme Lepage, Eric Vicaut, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 2024
Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network
Aurelien Fosse, Julien Hadoux, Paul Girot, et al.
Neoplasia (New York, N.Y.)
|
January 28, 2015
Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications
Alessio Imperiale, François-Marie Moussallieh, Philippe Roche, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 31, 2023
High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Ophélie De Rycke, Marine Perrier, Éric Ouvrard, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 133) with videos related to
Sort By:
Page
of 14
Endocrine
|
December 23, 2024
Organ-specific response to [<sup>177</sup>Lu]DOTATATE peptide receptor radionuclide therapy (PRRT) assessed by sequential [<sup>68</sup>Ga]DOTATOC PET/CT in patients with metastatic small intestine neuroendocrine tumors
Darejan Mamulashvili Bessac, Philippe Baltzinger, Nathan Poterszman, et al.
Journal of Clinical Medicine
|
September 29, 2017
History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs
Emmanuel Andrès, Rachel Mourot-Cottet, Frédéric Maloisel, et al.
QJM : Monthly Journal of the Association of Physicians
|
January 11, 2017
Idiosyncratic drug-induced neutropenia & agranulocytosis
Emmanuel Andrès, Rachel Mourot-Cottet, Frédéric Maloisel, et al.
Drugs - Real World Outcomes
|
October 18, 2016
Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases
Rachel Mourot-Cottet, Frédéric Maloisel, François Séverac, et al.
Endocrine
|
July 1, 2017
Management of gastric neuro-endocrine tumours in a large French national cohort (GTE)
Sylvain Manfredi, Thomas Walter, Eric Baudin, et al.
Annals of Surgery
|
March 21, 2018
Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study from the French Group of Endocrine Tumors (GTE)
Bérénice Rault-Petit, Christine Do Cao, Serge Guyétant, et al.
Advances in Therapy
|
April 14, 2022
Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study
Denis Smith, Côme Lepage, Eric Vicaut, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 2024
Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network
Aurelien Fosse, Julien Hadoux, Paul Girot, et al.
Neoplasia (New York, N.Y.)
|
January 28, 2015
Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications
Alessio Imperiale, François-Marie Moussallieh, Philippe Roche, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 31, 2023
High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Ophélie De Rycke, Marine Perrier, Éric Ouvrard, et al.
Page
of 14